109 results on '"Minsky, B.D."'
Search Results
2. Salvage Abdominoperineal Resection for Locally Recurrent or Persistent Anal Squamous Cell Carcinoma after Definitive Chemoradiation
3. Predictors of Low Anterior Resection Syndrome after Long-Course Chemoradiation for Locally Advanced Rectal Cancer
4. Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial
5. A Biology-Driven Radiomics Model for Unresectable Intrahepatic Cholangiocarcinoma Treated with Radiotherapy
6. Trial in Progress: 2019-1001 A Phase I Study of NBTXR3 Activated by Radiotherapy for Locally Advanced or Borderline Resectable Pancreatic Ductal Adenocarcinoma (LAPC or BRPC)
7. Patient-Reported Bowel Function and Quality of Life Following Short and Long Course Radiotherapy for Locally Advanced Rectal Cancer
8. Single Photon Emission Computed Tomography (SPECT) Functional Liver Imaging to Facilitate Reirradiation for Liver Malignancies: A Phase 1 Trial
9. Long-Term Patient-Reported Quality of Life and Functional Outcomes After Chemoradiation Using Intensity Modulated Radiotherapy for Anal Cancer
10. Stereotactic vs. Conventional Radiation Therapy in Patients With Pancreatic Cancer
11. Association of Gut Microbiome Characteristics With the Late Gastrointestinal Toxicities After Pelvic Receiving Radiation Treatment for Cervical, Vaginal, and Anal Cancers
12. Effect of Radiotherapy (RT) on Outcomes in Patients (Pts) With Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BRPC, LAPC)
13. PH-0111 Impact of body-mass index on multimodal treatment and outcome in locally advanced rectal cancer
14. Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience
15. International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer
16. Nurse Practitioner Navigation Program within a Rapid Access Bone Metastases Clinic Improves Patient Access to Radiation
17. Neutrophil-Lymphocyte Ratio and Tumor Interface Response as Predictors of Outcomes for Prospective Cohort of Patients with Pancreatic Ductal Adenocarcinoma
18. Patient-Reported Outcomes in Prospective Cohort of Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Undergoing Radiotherapy
19. IMRT Reduces Acute Toxicity in Patients Treated with Preoperative Chemoradiation for Gastric Cancer
20. Patient Setup Management for Pancreatic SBRT: Daily CT Based Assessment of Setup Accuracy using Vertebral Bone, Fiducial Markers, Biliary Stent, and Soft-Tissue Targeting
21. The transformation of radiation oncology using real-time magnetic resonance guidance: A review
22. Time-Driven Activity-Based Costing (TDABC) in Radiation Oncology: A Method for Implementation
23. Short-Course Radiation As a Component of Definitive Multidisciplinary Treatment for Select Patients with Metastatic Rectal Adenocarcinoma
24. Utility of Tumor Interface Stability as an Imaging Biomarker of Treatment Outcomes in Patients With Pancreatic Cancer Treated With Concurrent Bevacizumab and Radiation Therapy
25. Targeting Multiple Liver Segments, Including the Entire Right Lobe, With Ablative Radiation Therapy as Salvage Therapy for Patients With Colorectal Liver Metastases Not Eligible for Two-Stage Hepatectomy
26. Outcomes Following Hyperfractionated Accelerated Reirradiation for Recurrent Anal Cancer
27. Hyperfractionated Accelerated Reirradiation for Rectal Cancer: A Large Single-Institution Retrospective Analysis
28. Proton Therapy Outcomes for Localized, Unresectable Hepatocellular Carcinoma
29. The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010
30. Radiation Therapy for High-Grade Neuroendocrine Carcinoma of the Rectum and Anal Canal
31. Paraneoplastic Thrombocytosis Is a Significant Independent Prognostic Factor for Overall and Progression Free Survival in Locally Advanced Pancreatic Cancer
32. Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2).
33. Quality of Life After Intensity Modulated Radiation Therapy (IMRT) for Anal Cancer
34. The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007
35. Sociodemographic Factors Associated With Management of Gastric Cancer: QRRO/CURE Results
36. Impact of Co-morbidities on Practice Patterns in the Management of Gastric Cancer: Findings from the Quality Research in Radiation Oncology (QRRO) GI Committee Process Survey
37. Combined Modality Therapy for Rectal Cancer: Analysis of Potential Differences in Disease Presentation, Treatment Adherence, and Treatment Outcome According to Race
38. Quality Research in Radiation Oncology (QRRO): A Patterns of Care Analysis of Clinical Performance Measures in the Management of Gastric Cancer (GC)
39. Assessment of Emerging Technologies Used in Adjuvant Radiotherapy for Gastric Cancer: Preliminary Findings from the Quality Research in Radiation Oncology (QRRO) GI Committee Process Surveys
40. 6044 Multidisciplinary rectal cancer treatment: ‘Looking for an European Consensus’ (EURECA-CC2)
41. Squamous Cell Carcinoma of the Anal Canal: Patterns and Predictors of Failure and Implications for Intensity Modulated Radiation (IMRT) Planning
42. Toxicity of Radiotherapy for Rectal Cancer in Patients with Inflammatory Bowel Disease
43. 142
44. Combined modality therapy of resectable rectal cancer: current approaches
45. Recursive partitioning analysis (RPA) of pre-treatment variables for 416 patients with loco-regional esophageal cancer treated with concomitant chemoradiotherapy (CT-RT) on intergroup and radiation therapy oncology group (RTOG) trials
46. The national standards of practice for patients receiving radiation therapy for carcinoma of the esophagus: results of the 1996-1999 patterns of care study
47. A pathologic response score system after preoperative combined modality therapy as a predictor of metastases-free survival in the management of rectal carcinoma
48. Extent of gross or microscopic perirectal fat invasion does not predict outcome in T3N0 rectal cancers
49. Conservative treatment of rectal cancer with local excision and postoperative radiation therapy
50. The use of a prosthetic tissue expander to displace bowel from a brachytherapy implant site
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.